報價延遲最少15分鐘:2025/10/22 13:54 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.85 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.53/--
|
|
企業價值
9.28M
|
| 資產負債 |
|
每股賬面淨值
1.80
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
5.31M
|
|
每股收益
1.89
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/10/22 13:54 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America. |
